BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 1698007)

  • 1. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
    Mann DM; Jones D; Prinja D; Purkiss MS
    Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
    Armstrong RA
    Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
    Joachim CL; Morris JH; Selkoe DJ
    Am J Pathol; 1989 Aug; 135(2):309-19. PubMed ID: 2675616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abundance of the longer A beta 42 in neocortical and cerebrovascular amyloid beta deposits in Swedish familial Alzheimer's disease and Down's syndrome.
    Kalaria RN; Cohen DL; Greenberg BD; Savage MJ; Bogdanovic NE; Winblad B; Lannfelt L; Adem A
    Neuroreport; 1996 May; 7(8):1377-81. PubMed ID: 8856679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
    Kida E; Choi-Miura NH; Wisniewski KE
    Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
    Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
    Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites.
    Li YT; Woodruff-Pak DS; Trojanowski JQ
    Neurobiol Aging; 1994; 15(1):1-9. PubMed ID: 8159255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains.
    Armstrong RA; Cairns NJ; Myers D; Smith CU; Lantos PL; Rossor MN
    Neurodegeneration; 1996 Mar; 5(1):35-41. PubMed ID: 8731380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.
    Mann DM; Jones D
    Neurosci Lett; 1990 Feb; 109(1-2):68-75. PubMed ID: 2138261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
    Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
    Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spatial patterns of beta/A4 deposit subtypes in Down's syndrome.
    Amstrong RA
    Acta Neuropathol; 1994; 88(4):353-8. PubMed ID: 7839828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; CastaƱo EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early amyloid-beta deposits show different immunoreactivity to the amino- and carboxy-terminal regions of beta-peptide in Alzheimer's disease and Down's syndrome brain.
    Kida E; Wisniewski KE; Wisniewski HM
    Neurosci Lett; 1995 Jun; 193(2):105-8. PubMed ID: 7478152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly.
    Zhan SS; Veerhuis R; Kamphorst W; Eikelenboom P
    Neurodegeneration; 1995 Sep; 4(3):291-7. PubMed ID: 8581561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin histochemistry of cerebral microvessels in ageing, Alzheimer's disease and Down's syndrome.
    Mann DM; Purkiss MS; Bonshek RE; Jones D; Brown AM; Stoddart RW
    Neurobiol Aging; 1992; 13(1):137-43. PubMed ID: 1531863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta A4 deposition in the temporal cortex of adults with Down's syndrome.
    Spargo E; Luthert PJ; Janota I; Lantos PL
    J Neurol Sci; 1992 Aug; 111(1):26-32. PubMed ID: 1402995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
    Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
    Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.